Shenzhen Dazhou Medical Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenzhen Dazhou Medical Technology - overview
Established
2019
Location
Shenzhen, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Based in Shenzhen, China, and established in 2019, Shenzhen Dazhou Medical Technology is a medical company that develops biomaterials and medical equipment through three-dimensional printing technology. It has been selected for the 2022 Venture50 New Talent List and 2022 Investment Community Healthcare Venture50. In May 2020, the company closed an angel funding. As of 2024, it has applied for and obtained more than 20 national invention patents.
The founder, CEO, and chairman of the board, Jingzhou Yang, graduated from Harvard University. The company specializes in the business of biomedical materials, 3D printed orthopedic and dental innovative implant devices, bioprinting, and regenerative medicine products. The products include 3D printed bimetallic orthopedic implant material Tanlumbone, biomimetic human tissue porous scaffold, etc. The company generates revenue by providing biomedical materials, 3D-printed orthopedic implants, bioprinting, and regenerative medicine products.
Current Investors
Shenzhen Capital Real Estate Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Medical Devices & Equipment, Biomaterials
Website
www.dazhoumedical.com
Verticals
3D Printing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.